Loading...
XWARMDG
Market cap40mUSD
Dec 23, Last price  
16.79PLN
1D
-1.24%
1Q
-21.47%
Jan 2017
-94.55%
IPO
-20.05%
Name

Medicalgorithmics SA

Chart & Performance

D1W1MN
XWAR:MDG chart
P/E
—
P/S
3.88
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
22.51%
Rev. gr., 5y
-26.39%
Revenues
43m
-31.28%
4,107,3115,804,96610,961,65815,697,40029,714,10049,330,500127,921,000203,354,000199,404,000173,870,000111,734,000120,563,00062,719,00043,098,000
Net income
-578k
L
1,909,9853,005,8727,438,75210,874,10014,526,30013,925,40040,108,00025,539,00014,416,000-299,000-27,676,000-180,638,00018,088,000-578,000
CFO
182k
-97.13%
1,669,3692,688,8184,112,9205,576,900-2,907,70017,347,10035,477,00028,611,00044,232,00013,499,000-3,956,000-6,479,0006,331,000182,000
Dividend
Jul 13, 20181.42 PLN/sh

Profile

Medicalgorithmics S.A. provides cardiac diagnostic solutions in Poland, the United States, and internationally. The company offers PocketECG, a diagnostic solution for the diagnosis of arrhythmia that provides disclosure ECG signal, complete data, analysis, and comprehensive reporting; and PocketECG CRS for cardiac rehabilitation monitoring. It also provides ECG TechBot, a software using a set of algorithms for automatic analysis and interpretation of the ECG signal; PatchECG, a device enabling single-channel offline monitoring; and PocketECG IV that enables the PocketECG to be connected over the LTE band for continuous ECG signal transmission. In addition, the company offers information technology, biotechnology, ECG monitoring, and scientific research and development services; and manufactures and sells electro-medical equipment. Medicalgorithmics S.A. was founded in 2005 and is headquartered in Warsaw, Poland.
URL
https://www.medicalgorithmics.com/
IPO date
Nov 09, 2011
Employees
122
Domiciled in
PL
Incorporated in
PL

Valuation

Title
PLN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
43,098
-31.28%
62,719
-47.98%
120,563
7.90%
Cost of revenue
40,443
20,018
42,274
Unusual Expense (Income)
NOPBT
2,655
42,701
78,289
NOPBT Margin
6.16%
68.08%
64.94%
Operating Taxes
340
(216)
16,278
Tax Rate
12.81%
20.79%
NOPAT
2,315
42,917
62,011
Net income
(578)
-103.20%
18,088
-110.01%
(180,638)
552.69%
Dividends
Dividend yield
Proceeds from repurchase of equity
13,870
11,447
BB yield
-19.84%
-13.29%
Debt
Debt current
9
1,519
Long-term debt
1,394
5,513
18,511
Deferred revenue
(4,244)
14,116
Other long-term liabilities
16,771
8,760
144
Net debt
(24,107)
(20,663)
8,266
Cash flow
Cash from operating activities
182
6,331
(6,479)
CAPEX
(488)
(12,374)
(15,879)
Cash from investing activities
1,963
(1,812)
(15,776)
Cash from financing activities
(2,809)
9,979
17,725
FCF
1,463
60,887
60,540
Balance
Cash
25,501
26,165
11,667
Long term investments
20
97
Excess cash
23,346
23,049
5,736
Stockholders' equity
(118,416)
80,079
47,394
Invested Capital
227,753
65,674
65,447
ROIC
1.58%
65.46%
40.58%
ROCE
2.43%
44.01%
103.61%
EV
Common stock shares outstanding
9,953
5,701
4,547
Price
30.55
149.18%
12.26
-35.27%
18.94
-16.56%
Market cap
304,064
335.03%
69,894
-18.84%
86,120
-8.32%
EV
279,966
49,240
94,395
EBITDA
5,021
46,924
95,822
EV/EBITDA
55.76
1.05
0.99
Interest
105
271
888
Interest/NOPBT
3.95%
0.63%
1.13%